Innovate for Life:

A World Where
Cancer is Conquered,
Our Promise to
The Global Cancer Crisis

Confronting the
Challenge: Cancer's Global Impact.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

Global cancer diagnoses will reach 35 million in 2050, according to new estimates from the World Health Organization – an increase of 77% from the 20 million cases diagnosed in 2022.

Breast Cancer

Breast
Cancer

Occurs in breast tissue,
mainly affecting women.
Early detection is vital.
Lung Cancer

Lung
Cancer

Starts in the lungs.
Symptoms include
coughing and chest pain.
Colon Cancer

Colon
Cancer

Begins as polyps in the
large intestine. early
treatment is crucial.

Rectum Cancer

Rectal
Cancer

Develops in the rectum,
with symptoms including bleeding through the anus.

Prostate Cancer

Prostate
Cancer

Affects men’s prostate
gland and often growing
at a slow pace.

Breast Cancer

Breast
Cancer

Occurs in breast tissue, mainly affecting women. Early detection is vital.

Lung Cancer

Lung
Cancer

Starts in the lungs. Symptoms include coughing and chest pain.

Colon Cancer

Colon
Cancer

Begins as polyps in the large intestine. early treatment is crucial.

Rectum Cancer

Rectal
Cancer

Develops in the rectum, with symptoms including bleeding through the anus.

Prostate Cancer

Prostate
Cancer

Affects men’s prostate gland and often growing at a slow pace.

The Path to Curing Cancer

Many cancers can
be cured if detected early and treated effectively.

By 2024, there are projected to be 2,001,140 new cancer cases worldwide.

In the same year, 611,720 cancer deaths are anticipated globally.

Our Solutions

OncoTech’s Inventive Solutions

EARLY CANCER DETECTION

The world’s first clinically tested and validated on-demand cancer and diabetes screening system powered by advanced AI.

Our Solutions

OncoTech’s Inventive Solutions

EARLY CANCER DETECTION

The world’s first clinically tested and validated on-demand cancer and diabetes screening system powered by advanced AI.

ANTI-CANCER TREATMENT

An innovative anti-cancer immunotherapy based on DHMEQ and drug combinations for various cancer types.

"WHO’s new global survey sheds light on major inequalities and lack of financial protection for cancer around the world, with populations, especially in lower income countries, unable to access the basics of cancer care."

Dr. Bente Mikkelsen
Director of WHO’s Department of Noncommunicable Diseases.

Oncotech’s mission to conquer Cancer worldwide by making its solutions cost-effective, thus, enabling its adoption in every corner of the world regardless of socioeconomic status.  Because every life matters!.

OUR TEAM

Our Leadership Team

OUR SCIENCE TEAM

Our Oncological Science Team

Contact Us

Want to Learn More?

Get in Touch



    Ring Us

    Work and general inquiries
    + 46 761 333 396

    Assistance hours:
    Monday – Friday
    9 am to 6 pm CET

     
    Address

    ONCOTECH LTD
    1 Charterhouse Mews, London, EC1M 6BB, United Kingdom.

    ONCOTECH NORDIC AB
    Vastra Ljungbyvagen 275 26651 Vejbystrand, Sweden.

    Get in Touch



      Ring Us

      Work and general inquiries
      + 46 761 333 396

      Assistance hours:
      Monday – Friday
      9 am to 6 pm CET

       
      Address

      ONCOTECH LTD
      1 Charterhouse Mews, London, EC1M 6BB, United Kingdom.

      ONCOTECH NORDIC AB
      Vastra Ljungbyvagen 275 26651 Vejbystrand, Sweden.